User:Pia.Arriane/Presidio Partners

Presidio Partners
Presidio Partners, formerly known as CMEA Capital, is a venture capital firm based in San Francisco, California. The firm was established in 1989 and has since been active in the investment industry. Presidio Partners' investment strategy is diverse, focusing on seed-stage, early-stage, and later-stage companies across various sectors. Notable successful investments made by the firm include Wildcat Discovery Technologies, Exela Pharma Science, Tetraphase Pharmaceuticals, Odyssey Logistics & Technology Corp., Arcadia Biosciences, and  LiveOps.

Investment Strategy
Presidio Partners typically invests in seed-stage, early-stage, and later-stage companies, providing capital and strategic guidance to help businesses grow and succeed. The firm's investment strategy is not confined to a specific stage but rather is flexible, adapting to the needs and opportunities presented by each individual company.

Sector Focus
Presidio Partners has a broad sector focus, investing in companies in the energy, healthcare, information technology, and life sciences sectors. This multi-sector approach allows Presidio Partners to leverage cross-industry knowledge and foster innovation through the integration of different sector-specific insights.

History
Founded in 1989 as CMEA Capital, Presidio Partners rebranded in 2015. Over the years, the firm has built a strong track record and reputation for its investment strategy and sector focus.